CTHRC1 and neoplasm: Crucially, in vitro validation confirms that CTHRC1+ CAFs secrete WNT5A, which upregulates the mesothelin (MSLN) gene in CRC tumor cells - an effect abolished by WNT5A inhibition or CTHRC1 knockdown.